Bergman R
Guinter Kahn MD Department of Dermatology, Rambam Medical Center, Haifa, Israel.
J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):236-42. doi: 10.1016/s0190-9622(94)70023-0.
Xanthelasma palpebrarum is the most common type of xanthoma. On average, only half the patients with xanthelasma palpebrarum are hyperlipidemic. This review is an attempt to elucidate the pathogenesis and clinical significance of xanthelasma palpebrarum, especially its suggested role as a marker for increased risk for atherosclerosis. In hyperlipidemic patients with xanthelasma, the risk for atherosclerosis may be inferred from the associated lipoprotein and apolipoprotein abnormalities. The possible risk for atherosclerosis in normolipidemic patients with xanthelasma is more obscure because of the relative paucity of epidemiologic data and the conflicting results in some of the lipid studies. Several studies, however, showed decreased high-density lipoprotein cholesterol levels and other lipoprotein and apolipoprotein abnormalities that are associated with atherosclerosis. Therefore, on the basis of the present data, determining the plasma lipoprotein and apolipoprotein levels (especially those associated with increased risk for atherosclerosis) in each normolipidemic patient with xanthelasma appears to be justified.
睑黄瘤是最常见的黄瘤类型。平均而言,只有半数睑黄瘤患者存在高脂血症。本综述旨在阐明睑黄瘤的发病机制及临床意义,尤其是其作为动脉粥样硬化风险增加标志物的潜在作用。在患有睑黄瘤的高脂血症患者中,动脉粥样硬化风险可从相关的脂蛋白和载脂蛋白异常情况推断出来。由于流行病学数据相对匮乏以及一些脂质研究结果相互矛盾,睑黄瘤的血脂正常患者发生动脉粥样硬化的潜在风险更为不明朗。然而,多项研究显示高密度脂蛋白胆固醇水平降低以及其他与动脉粥样硬化相关的脂蛋白和载脂蛋白异常情况。因此,基于目前的数据,对每例睑黄瘤血脂正常患者测定血浆脂蛋白和载脂蛋白水平(尤其是那些与动脉粥样硬化风险增加相关的指标)似乎是合理的。